ExonHit Therapeutics SA

Type: Company

Name: ExonHit Therapeutics SA

Fact Sheet: Fact Sheet for ExonHit Therapeutics SA

First Reported 11/02/2009 - Updated 11/02/2009 - 2 Documents (in Medicine)

ExonHit announces participation in MAPT study

Therapeutic and diagnostic company ExonHit Therapeutics (Paris: ALEHT) said today that, together with Toulouse University Hospital and l'Institut de Recherche Pierre Fabre (IRPF), it will participate in the Multidomain Alzheimer Preventive Trial (MAP ... [M2 - 11/02/2009]

Entities: Alzheimer's Disease, ExonHit Therapeutics SA, Diagnostic, Pierre Fabre

First Reported 10/30/2009 - Updated 10/30/2009 - 3 Documents (in Health)

ExonHit Presents Clinical Advances on Alzheimer’s Programs

ExonHit Therapeutics presented clinical data on the validation set “Alzheimer patients versus healthy controls” for AclarusDx (formerly EHTDx21), its blood-based diagnostic test for the detection of Alzheimer’s disease. ... [FDA News - 10/30/2009]

Entities: Alzheimer's Disease, ExonHit Therapeutics SA

First Reported 10/26/2009 - Updated 10/26/2009 - 2 Documents

USPTO reaffirms the validity of ExonHit Therapeutics' SpliceArray patent

USPTO reaffirms the validity of core SpliceArray™ patentExonHit (Paris:ALEHT) is pleased to announce that the United States Patent and Trademark Office (“USPTO”) notified the Company of its intent to issue a Re-examination Certificate in connection with ... [News-Medical.Net - 10/26/2009]

Entities: USPTO, ExonHit Therapeutics SA, Patent

First Reported 10/28/2009 - Updated 10/28/2009 - 1 Documents (in Internet & IT)

ExonHit Strengthens Its IP ...

PARIS - ExonHit announced in a press release that the United States Patent and Trademark Office (USPTO) notified the company of its intent to issue a Re-examination Certificate in connection with ExonHit's US Patent No. 6,881,571 directed to the use of ... [Intellectual Property News Agency - 10/28/2009]

Entities: USPTO, Patent, ExonHit Therapeutics SA, Biologics

First Reported 10/29/2009 - Updated 10/29/2009 - 1 Documents (in Biology)

DeCODE genetics

Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly

Reportlinker.com announces that a new market research report is available in its catalogue.http://www.reportlinker.com/p0156566/Molecular-Diagnostics-A-Dynamic-and-Rapidly-Broadening-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnews ... [PR Newswire via MSN Money - 10/29/2009]

Entities: Molecular Diagnostics, CombiMatrix, Diagnostic, ExonHit Therapeutics SA, DeCODE genetics

First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents

ExonHit Therapeutics names Herve Duchesne de Lamotte as CFO

ExonHit Therapeutics (Paris: ALEHT) has appointed Herve Duchesne de Lamotte as its Chief Financial Officer.Making the announcement today, the company said that de Lamotte has over 25 years of international financial experience, including 10 years within ... [M2 - 11/05/2009]

Entities: ExonHit Therapeutics SA, Cirrus, Paris

First Reported 11/11/2009 - Updated 11/11/2009 - 1 Documents

TRIN Pharma names Stefan Wohlfeil CEO

TRIN Pharma GmbH has appointed Stefan Wohlfeil as to be the company's new CEO. ReleaseRXi Pharmaceuticals has announced that Noah D. Beerman has joined the company as its new President and CEO. ReleaseAmarin Corporation has announced the appointment of ... [FierceBiotech - 11/11/2009]

Entities: ExonHit Therapeutics SA, EpiCept Corporation, Emisphere Technologies Inc

Quotes

...Loïc Maurel, president of the ManagementManagement Board of ExonHit Therapeutics. "This decision rewards ExonHit's determination to defend its Intellectual Property" he added. All rejections have been withdrawn and all claims are allowed, in view of clarifying amendments made to two of the claims

ExonHit Strengthens Its IP ... [Intellectual Property News Agency - 10/28/2009]

More Content

sort by: Date \| Relevance
TRIN Pharma names Stefan Wohlfeil CEO [FierceBiotech - 11/11/2009]
ExonHit Therapeutics names Herve Duchesne de La... [M2 - 11/05/2009]
ExonHit announces participation in MAPT study [M2 - 11/02/2009]
ExonHit Therapeutics to take part in MAPT study... [News-Medical.Net - 11/02/2009]
ExonHit Presents Clinical Advances on Alzheimer... [FDA News - 10/30/2009]
Clinical data on the validation set 'Alzheimer ... [News-Medical.Net - 10/30/2009]
ExonHit Presents New Clinical Advances on Its A... [Business Wire - 10/30/2009]
Reportlinker Adds Molecular Diagnostics: A Dyna... [PR Newswire via MSN Money - 10/29/2009]
ExonHit Strengthens Its IP ... [Intellectual Property News Agency - 10/28/2009]
With USPTO Re-Exam Over, ExonHit and Jivan Like... [GenomeWeb - 10/27/2009]
USPTO reaffirms the validity of ExonHit Therape... [News-Medical.Net - 10/26/2009]
ExonHit Strengthens Its Intellectual Property P... [Business Wire - 10/26/2009]

Change Password

Log in to Silobreaker

Advanced Search Options

ExonHit Therapeutics SA